Teva also develops branded drug activity with its multiple sclerosis treatment Copaxone3,3 $B (2010)… </li></li></ul><li>Teva profile (product sales)<br />With current 16,1 $B annual sales, Teva has showed impressive growth late 10 years thanks to important M&A. <br />
Teva profile (Product sales)<br />MS drug Copaxone is taking a growing part in Tevapharmaceutical business (20% in 2008)<br />
Current key TO Chephalon narcolepsy treatment Provigil will lose patent April 2012.</li></li></ul><li>Whatis the point ?<br /><ul><li>“This is transforming for Teva’s branded business, as it will help us to deliver on our strategic goal of creating a diversified, multi-faceted company,” said Teva Chief Executive ShlomoYanai.
TEVA which doesn’t want to be generic company exclusively ,will benefit of an existing branded drugs portfolio from Cephalon (20) as well as will integrate 20 to 30 drugs in phase 2/3 development stage.
This should provide additional TO to TEVA for the next few years.</li></ul>Link to more detailed Cephalon pipeline presentation<br />
The agreement<br /><ul><li>In march 2011 the canadianValeantlaunched a hostile Cephalonbid of 5.7 $B (73 $ per share, +29% on regularCephalon value share).
TEVA offered a non-hostile 12% up bid for Cephalon, at 81,5 $ a share.</li></li></ul><li>Furtherreading<br /><ul><li>Linksforpharmarecomends the following resources:
http://www.bnet.com/blog/drug-business/can-cephalon-a-company-in-mourning-fend-off-the-hostile-borg-at-valeant/7855?tag=content;drawer-container</li></li></ul><li>Presentationsfromlinksforpharma<br /><ul><li>Linksforpharma.com is a pharmaceutical industry dedicated portal.
Linksforpharma.com provides a selection of resources from the internet on the pharma sector.
Registered people at Linksforpharma may publish individual profile as well as company profile to built a sectorial community.
As a free service, linksforpharma.com creates and publishes presentations, illustrating news and development in the pharma field.
Presentations from linksforpharma (of which this one), have been made thanks to internet publicly available information, such as: articles, blog posts, press releases, yahoo finance, google news, etc…</li>